# Meningococcemia

> Describe the clinical features, investigation, treatment and prevention of meningococcaemic shock. (UMM)

## Clinical Features

- Acute Meningoccemia
  - Influenza like symptom
  - Morbilliform rash
  - Petechial or purpuric spots
  - Hypotension
  - DIC
  - Renal failure
  - Coma
  - Death if undiagnosed early
- Meningococal meningitis
  - Convulsion
  - Coma
  - Death
- Acute endocarditis, myocarditis, pericarditis
- Chronice meningococcemia
  - Anorexia
  - Weight loss
  - Rash
  - Arthritis
  - Erythema nodosum

## Investigation

- Culture and sensitivity
  - from skin lesion, nasopharynx, blood and CSF
- Lumbar puncture if meningitis is suspected
- Complete blood count (CBC)
  - Neutropil leucocytosis
- Rapid diagnostic test by Counter current immunoelectrophoresis, immunoassay

## Treatment

- Antibiotics
  - `IV crystalline penicillin 1L/kg/dose 6 hourly` **Or**
  - `3rd generation cephalosporin` (e.g., `Cefotaxime 50 mg/kg/dose 6 hourly for 7-10 days`)
- Fluids: `Colloids` and `inotropes` in shock
- Steroid: `IV hydrocortisone` in adrenal haemorrhage
- DIC: Fresh whole blood, Fresh plasma

## Prevention

- Vaccination
  - Meningococcal vaccine to household and daycare nursery contacts
  - Bootster after 3 months and 12-18 months
- Drugs
  - `Rifampicin 10 mg/kg BD for 2 days` to household and daycare nursery contacts
  - `Ciprofloxacin 500 mg single dose` (adult contact)
